Cardiogenesis Announces Passing of Director, Joseph R. Kletzel, II (RedNova)
IRVINE, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation , is deeply saddened to announce that Joseph R. Kletzel, II, valued member of the Cardiogenesis Board of Directors, died on Monday, January 15.

CEL-SCI Receives Green Light From FDA to Proceed With Phase III Cancer Study (PR Newswire via Yahoo! Finance)
CEL-SCI Corporation , today announced that the U.S. Food and Drug Administration has stated in a letter to the Company that, "...the proposed Phase III study may proceed at any time."